Broadwood Capital, 10% Owner: Lineage Cell Therapeutics LCTX Buy · Filed 24/02/08

Trade details

Type: Insider buy
Amount: $7,000,000.8
Shares · price: 6,730,770 sh · $1.04 a share
Held after: 41,666,255 sh
Stock: Lineage Cell Therapeutics LCTX
Person: Broadwood Capital10% Owner
Trade date: 24/02/06
Filed: 24/02/08
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 4 insiders
Holding change: +19.3%

Lineage Cell Therapeutics trades, last 26 weeks

What else happened in Lineage Cell Therapeutics around then

Filed or reported within 30 days of the trade day · 24/01/07~24/03/07

Broadwood Capital's recent trades

Broadwood Capital10% Owner
BuyInsight Molecular Diagnostics
Buy
Insight Molecular Diagnostics
IMDX
$981.3K
280,381 sh
$981.3K
Filed 04/27
Traded 04/23
Broadwood Capital10% Owner
BuyInsight Molecular Diagnostics
Buy
Insight Molecular Diagnostics
IMDX
$913.4K
250,923 sh
$913.4K
Filed 04/27
Traded 04/27
Broadwood Capital10% Owner
BuyInsight Molecular Diagnostics
Buy
Insight Molecular Diagnostics
IMDX
$137.2K
38,880 sh
$137.2K
Filed 04/27
Traded 04/24
Broadwood Capital10% Owner
BuyInsight Molecular Diagnostics
Buy
Insight Molecular Diagnostics
IMDX
$0
0 sh
$0
Filed 04/27
Traded 04/24
Broadwood Capital10% Owner
BuyInsight Molecular Diagnostics
Buy
Insight Molecular Diagnostics
IMDX
$0
0 sh
$0
Filed 04/27
Traded 04/27

Broadwood Capital, 10% Owner — bought $7M of Lineage Cell Therapeutics LCTX · 6,730,770 sh @ $1.04 | Whalegun